Modern Advances and Evidence According to the Results of the European Congress of Cardiologists in Amsterdam (30.08–04.09.2013)

Journal Title: Lviv Clinical Bulletin - Year 2013, Vol 4, Issue 4

Abstract

Introduction. According to the President of the European Congress of Cardiologists (European Society of Cardiology, ESC) Professor Panos Vardasa, despite the progress of medicine, the diseases of cardiovascular system is now the number one killer of the population of Europe. Clinical trials based on the clinical practice and guidelines were presented at the annual European Congress of Cardiologists in Amsterdam. Aim. To conduct a description and discussion of current successes and evidence of the results of the European Congress of Cardiologists in Amsterdam (30.08-04.09.2013). Materials and methods. Information is provided on the results of the European Congress of Cardiologists in Amsterdam (30.08 - 04.09.2013). The description of clinical trials and updated recommendations on the diagnosis, treatment and prevention of the diseases of the cardiovascular system, including arterial hypertension and cardiovascular disease in patients with diabetes mellitus and pre-diabetes. Results. Among a number of important issues presented during the Congress there were published the results of such studies: HOKUSAI-VTE – using of anticoagulant edoxaban per os for the treatment of venous thromboembolism showed the equal efficacy but better tolerability and safety as compared with warfarin for the primary purpose of low molecular heparin; TASTE - aspiration of blood clots and clots that cause heart attack before opening the artery balloon does not improve the survival compared to using only a balloon dilation or stenting without aspiration; ECHOCRT - the results confirmed the underlying principles that cardiac resynchronization treatment should not be performed for the patients with a narrow QRS complex; DECAAF – the results showed that in patients with atrial fibrillation magnetic resonance imaging prior to ablation allows to determine the extent of damage of the heart tissue. PRAMI - the primary endpoint was the combined death from the cardiac causes, nonfatal myocardial infarction or refractory angina in patients with STEMI and concomitant hemodynamically significant stenosis of the coronary arteries. In addition stenting of the infarct-dependent coronary arteries in all patients with acute elevation of ST-segment, additional preventive coronary artery stenting in the experimental group with hemodynamically significant stenosis showed the significant preference (p <0.001) of such treatment. The Congress also published the first findings on the elimination of the negative impact of lifestyle in the secondary prevention of cardiovascular diseases. At the Congress in Amsterdam there were also presented new recommendations - Recommendations of the European Society of Cardiologists and the European Society of Hypertension on the diagnosis, treatment and prevention of arterial hypertension and Recommendations for the prevention, diagnosis and treatment of cardiovascular disease in patients with diabetes and pre-diabetes. Conclusions. Presented description of the clinical trials and new guidelines for the diagnosis based on their findings, treatment and prevention of the cardiovascular diseases, especially arterial hypertension and cardiovascular diseases in patients with diabetes mellitus and pre-diabetes were provided that must be taken into account in the usual practice of a doctor.

Authors and Affiliations

A. Faynyk, M. Faynyk

Keywords

Related Articles

Content Dihydrotestosterone Levels in Postmenopausal Women According to the Comorbid Disease: Type 2 Diabetes and Hypertension

Introduction. Postmenopausal women ­ one of the most critical periods in which modern woman spends a third of her life, and therefore the study of this problem is of particular interest. Today is proved the activity of s...

Эволюция целевого уровня артериального давления у больных сахарным диабетом: анализ мирового опыта

Введение. Известно, что 75,0% осложнений сахарного диабета (СД) вследствие поражения сердечно-сосудистой системы или почек обусловлено артериальной гипертензией (АГ), которая у пациентов с СД наблюдается вдвое чаще, чем...

Pharmacotherapy with Using Vitamins and Minerals of Idiopathic Habitual Miscarriage

Introduction. The presence in the history of two spontaneous miscarriages and more in the first trimester is treated as the usual miscarriage of pregnancy. Endocrine factors, genital infections, extragenital diseases pla...

The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis

Introduction. Today, dyslipidaemia is considered one of the main risk factors for atherosclerosis and, as a consequence, cardiovascular disease. In turn, the liver plays a leading role in the onset of atherogenic dyslipi...

Возрастные особенности диаметра и деформабельности эритроцитов

Введение. Известно, что диаметр и деформабельность эритроцитов играют очень важную роль в поддержании нормальной микроциркуляции в организме человека. Целью исследования было изучение возрастных изменений диаметра и дефо...

Download PDF file
  • EP ID EP258015
  • DOI 10.25040/lkv2013.04.056
  • Views 110
  • Downloads 0

How To Cite

A. Faynyk, M. Faynyk (2013). Modern Advances and Evidence According to the Results of the European Congress of Cardiologists in Amsterdam (30.08–04.09.2013). Lviv Clinical Bulletin, 4(4), 56-62. https://europub.co.uk/articles/-A-258015